Dual-Energy CT Vital Iodine Tumor Burden for Response Assessment in Patients With Metastatic GIST Undergoing TKI Therapy: Comparison With Standard CT and FDG PET/CT Criteria
Authors:
- 1 April 2022
- journal article
- research article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 218 (4) , 659-669
Abstract
Background: CT-based criteria for assessing gastroinstestinal stromal tumor (GIST) response to tyroskine kinase inhibitor (TKI) therapy are limited partly because tumor attenuation is influenced by...Keywords
This publication has 36 references indexed in Scilit:
- Quantitative therapy response assessment by volumetric iodine-uptake measurement: Initial experience in patients with advanced hepatocellular carcinoma treated with sorafenibEuropean Journal of Radiology, 2013
- The use of tumour volumetrics to assess response to therapy in anticancer clinical trialsBritish Journal of Clinical Pharmacology, 2012
- Contrast-Enhanced Dual-Energy CT of Gastrointestinal Stromal TumorsInvestigative Radiology, 2012
- Comparison of RECIST and Choi criteria for computed tomographic response evaluation in patients with advanced gastrointestinal stromal tumor treated with sunitinibAnnals of Oncology, 2011
- Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)European Journal of Cancer, 2010
- Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSeminars in Liver Disease, 2010
- FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0European Journal of Nuclear Medicine and Molecular Imaging, 2009
- We Should Desist Using RECIST, at Least in GISTJournal of Clinical Oncology, 2007
- Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response CriteriaJournal of Clinical Oncology, 2007
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal of Cancer, 1999